May 06, 2021 01:37 PM IST

EU ready to 'discuss' COVID-19 vaccine patent waivers

European Commission President Ursula von der Leyen stressed that Europe's priority would be to boost global supplies, and implicitly criticised the US and the UK for limiting COVID-19 vaccine exports.

BioNTech eyes COVID-19 vaccine for 12-15 year olds from June in EU

The German firm's CEO Ugur Sahin told Der Spiegel weekly that it was "in the final stretches" of preparing its submission for European regulatory approval.

How the EU and AstraZeneca ended up in court, and what next

A first hearing in the case began at the Brussels Court of First Instance on Wednesday. The proceedings are public and conducted under an emergency procedure, which means they could be concluded in a matter of weeks, the European Union's executive Commission said.

EU launches legal action against vaccine-maker AstraZeneca

The AstraZeneca vaccine has been central to Europe’s immunization campaign, and a linchpin in the global strategy to get vaccines to poorer countries. But the slow pace of deliveries has frustrated the Europeans and has been blamed in part for holding up the EU’s vaccine rollout.

Glenmark Pharma to launch its nasal spray Ryaltris in European Union

Glenmark said Ryaltris is now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age.

Iran nuclear talks set to restart today in Vienna

The talks are aimed at determining which sanctions the United States should lift and the measures Iran has to take to come into compliance with the accord.

COVID-19 update | European Union to get 50 million Pfizer doses early as Denmark scraps AstraZeneca

Denmark becomes first country in EU to drop AstraZeneca vaccine over suspected side effects

Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.

Negotiations on India-EU trade deal to resume next month: FM Nirmala Sitharaman

The negotiations between India and the European Union on a free trade agreement have been stalled since May 2013, when both sides failed to bridge substantial gaps on crucial issues, including data security status for the IT sector. The negotiations with the 27-nation grouping were launched in June 2007.

EU agency to share results of probe into AstraZeneca shot

Earlier this week, a senior official from the European Medicines Agency said there was a causal link between the AstraZeneca vaccine and the rare clots that have been seen in dozens of people worldwide, among the tens of millions who have received at least one dose of the shot.

EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Report

The EU wants the doses from Serum, the world's largest vaccine maker, to offset supply shortfalls from AstraZeneca's European plants and speed up the bloc's vaccine roll-out.

Supply Isn’t the Only Thing Stymying Europe’s Vaccine Rollout

The temporary suspension last week by multiple countries of AstraZeneca, the vaccine that the European Union has bet on, was only one indication of how Europe’s rollouts have been plagued by an overabundance of caution, bad deals and flouted obligations by pharmaceutical companies that have created a supply shortage.

EU imposes China sanctions over Xinjiang abuses; first in three decades

While mainly symbolic, the sanctions mark a significant hardening in the EU's policy towards China, which Brussels long regarded as a benign trading partner but now views as a systematic abuser of basic rights and freedoms.

EU regulator 'convinced' AstraZeneca benefit outweighs risk

Experts have noted that such concerns are inevitable in mass vaccination campaigns — with so many people getting shots, some are bound to get sick even if the vaccine is not to blame.

EU's push for ethically sourced batteries will make electric vehicles more expensive

EU has been calling for responsibly-sourced cobalt, which will make the key battery metal expensive as the supply will be squeezed.

EU prepares to turn the screw on asset managers over greenwashing

From this week, all funds must disclose in their pre-contractual information how they factor sustainability risks into their investment decisions.

Exclusive | France said to be looking to secure Bharat Biotech COVID-19 vaccine

With less than 5 percent of its population inoculated so far, the Emmanuel Macron government is under tremendous pressure to secure more vaccines. Covaxin could likely be a beneficiary.

The ugly divorce between Britain and Brussels is just getting started

As trade disputes pile up, the blame game evident in the early months of the split suits domestic political needs on both sides.

EU prepares measures against Myanmar coup leaders

The EU ministers condemned the arrests and called for the unconditional release of the President, Suu Kyi and all those held since the coup.

Pfizer-BioNTech to get EU 200 million more COVID-19 shots

The Pfizer-BioNTech vaccine was the first of three so far to be approved for use in the EU, which has faced strong criticism for a slow start to its vaccination campaign compared with countries such as Israel, Britain and the United States. The other two EU-approved vaccines are from Moderna and AstraZeneca.

Foreign envoys in J&K to assess situation post Article 370

This is the third visit of foreign envoys to J&K after the abrogation of Article 370 and the erstwhile state's bifurcation into two union territories.

EU to launch programme for 'second generation' COVID-19 vaccines

The "HERA incubator" programme, which begins Wednesday, will bring together the pharmaceutical industry, laboratories, health authorities and researchers, Ursula von der Leyen told French daily Les Echos on Tuesday.

Johnson & Johnson files for EU COVID vaccine approval

The single-shot vaccine would be the fourth jab to be approved for use across the 27-nation European Union if it gets the green light from the Amsterdam-based European Medicines Agency.